Vol. 7, Issue 1, Part A (2025)

Background: Herbal medicine's natural origins are making it more and more popular in both developed and developing nations. Common names for Berberis lycium include Indian Barberry, Kashmal (Hindi), and Ishkeen (Urdu). It is a member of the Berberidaceae family. It has long been used in India's Jammu and Kashmir area. This spiky, evergreen plant is mostly found in the Himalayan region and is extensively recognized in Ayurvedic medicine for its therapeutic benefits. The root, bark, stem, leaves, fruits, and other components of the plant have all been used to treat problems with the kidneys, liver, stomach, skin, cough, oral ulcers, conjunctivitis, and more. Studies on pharmacology demonstrate that it has antihyperlipidemic, antiglycemic, hepatoprotective, antipyretic, wound-healing, anticancer, antibacterial, antifungal, and pesticidal qualities.
Methods: Through in-vitro tests, this study focuses on Berberis lycium's antibacterial qualities. A Soxhlet apparatus was used to extract different plant sections, and the conventional disc diffusion method was used to test the extracts against pathogenic bacterial strains (Pseudomonas sp., Escherichia coli, Streptococci sp., and Staphylococcus sp.). Alkaloids, terpenoids, steroids, proteins, carbohydrates, and flavonoids were all found via phytochemical screening. To evaluate the plant's safety profile, toxicological investigations were conducted, including acute and sub-chronic toxicity testing.
Results: When compared to other solvents, methanolic extracts of Berberis lycium showed the largest inhibitory zone (16 mm), indicating that the plant has strong antibacterial activity. Staphylococcus (10 mm), Pseudomonas (11 mm), and E. coli (12 mm) were all significantly inhibited by the methanolic extract, while Streptococcus was unaffected.
Conclusion: This study demonstrates that Berberis lycium has antibacterial properties, with the most effective extract being methanolic. The plant's use in herbal medicine, especially for the treatment of bacterial infections, is supported by its traditional and pharmacological relevance. To fully investigate its therapeutic potential and safety profile, more research is necessary.